US20130251710A1 - Methods to Expand the Eligible Patient ...,https://www.google.com/patents/US20130251710
EP3052937A2 - Breast cancer diagnostic method and means ...,https://www.google.com/patents/EP3052937A2?cl=en
CA2927477A1 - Method of determining disease causality of genome ...,https://www.google.com/patents/CA2927477A1?cl=ru
WO2012049225A2 - Markersequenzen f√ºr systemischer lupus ...,https://www.google.com/patents/WO2012049225A2?cl=de
US20130217591A1 - Marker Sequences for Inflammatory Prostate ...,https://www.google.com/patents/US20130217591
EP2712934A2 - Marker sequences for prostate inflammation ...,https://www.google.com/patents/EP2712934A2?cl=en
WO2017142485A1 - Cancer epigenetic profiling - Google Patents,https://www.google.com/patents/WO2017142485A1?cl=en
WO2007128884A1 - Novel genes and markers in type 2 diabetes ...,https://google.com/patents/WO2007128884A1?cl=fi
WO2014013258A1 - Stem cell microparticles - Google Patents,https://www.google.com/patents/WO2014013258A1?cl=ru
US20090227533A1 - miR-34 Regulated Genes and Pathways as ...,http://www.google.com/patents/US20090227533
